Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/GILD
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Gilead Sciences, Inc. (GILD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Gilead Sciences (GILD) trades at $143.44, up 3.25% today, with a bullish technical signal from moving averages and a consensus analyst price target of $149.50. Recent Q2 2026 earnings beat expectations despite a net loss, driven by strong HIV drug sales, while the company maintains a solid cash flow from operations of $10.02B in 2025. News highlights institutional buying and pipeline advancements in HIV and oncology.
The outlook is positive with raised 2026 guidance and a dominant HIV franchise, but risks include a net income margin of -10.64% for 2026 and high debt levels. The stock offers growth potential from pipeline catalysts, though investors face volatility from patent cliffs and acquisition integration challenges.
Read full analysis

Key Stats

  • Market Cap
    $183.02B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $155.80
  • 52W Low
    $110.56
  • Typical Hold Time
    -
  • Enterprise Value
    $206.08B
  • Div Yield
    2.22%
  • Trading Activity
    -
$146
52W Low: $110.56
02 Oct 2025
52W High: $155.8
11 Feb 2026

Track Gilead Sciences, Inc. (GILD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $110.56 and a high of $155.8, highlighting its annual price range. Buy and sell Gilead Sciences, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Most Recent News

Content is generated by Aura AI

Leveraged ETF GGLL lags 2X Alphabet's gains due to daily resets and volatility drag.

The Direxion Daily GOOGL Bull 2X ETF (GGLL) aims to deliver twice the daily return of Alphabet stock but often underperforms over longer periods due to daily resets, compounding effects, volatility drag, and fees. While Alphabet shares rose about 10%...

Market News
4 hours ago
24/7 Wall Street
Neutral
pluang ai news

iShares MSCI Mexico ETF lags peers despite gains in copper sector and Q2 GDP rebound

The iShares MSCI Mexico ETF (EWW), covering 39 stocks, has underperformed emerging market peers and global stocks this year. Its portfolio has shifted toward materials, especially Grupo Mexico B, which now makes up 16% of the fund and benefits from s...

Market News
4 hours ago
Seeking Alpha
Neutral
pluang ai news

Heliostar reports strong antimony and gold results at Utah's Goldstrike, starts drilling program.

Heliostar Metals announced promising surface sampling results from its Goldstrike property in Utah, revealing high antimony and gold grades over a large area including a new discovery at Antimony Knoll. The findings indicate a significant Carlin-styl...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $183.02B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $155.80
  • 52W Low
    $110.56
  • Typical Hold Time
    -
  • Enterprise Value
    $206.08B
  • Div Yield
    2.22%
  • Trading Activity
    -
$146
52W Low: $110.56
02 Oct 2025
52W High: $155.8
11 Feb 2026

Track Gilead Sciences, Inc. (GILD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Gilead Sciences, Inc. has traded between a low of $110.56 and a high of $155.8, highlighting its annual price range. Buy and sell Gilead Sciences, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!